Collectively, these findings suggest that high expression of PRP19 might impede B cell infiltration in HCC tissues, and the levels of PRP19 and B cell marker CD20 are associated with the prognostic outcomes of HCC patients. The gene discussed is MS4A1; the disease is hepatocellular carcinoma.